{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T21:23:05Z","timestamp":1757625785922,"version":"3.44.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000269","name":"Economic Social Research Council","doi-asserted-by":"crossref","award":["ES\/X004082\/1"],"award-info":[{"award-number":["ES\/X004082\/1"]}],"id":[{"id":"10.13039\/501100000269","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Institute for Health and Care Research Applied Research Collaboration North West Coast"},{"DOI":"10.13039\/501100000269","name":"Economic and Social Research Council","doi-asserted-by":"publisher","award":["ES\/X007375\/1","ES\/X005259\/1"],"award-info":[{"award-number":["ES\/X007375\/1","ES\/X005259\/1"]}],"id":[{"id":"10.13039\/501100000269","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institute for Health and Care Research Applied Research Collaboration South London"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>In England, people aged\u2009&gt;\u200960 are typically required to pay for their prescriptions. Whilst exemption criteria enable people living with specified long-term health conditions to receive free prescriptions, Parkinson\u2019s disease is omitted from this list. People with Parkinson\u2019s are often reliant upon medications, and evidence suggests that medical fees can reduce quality of life and medicine adherence. We, therefore, aimed to explore the impact of prescription charges on people with Parkinson\u2019s and their family care partners (caregivers).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This is a qualitative focus group study with people with Parkinson\u2019s and caregivers. Focus groups were semi-structured and conducted online. Participants were recruited through opportunity sampling. Eligible participants were adults aged 18 and over living in England who either (1) had a diagnosis of Idiopathic Parkinson\u2019s Disease or (2) provided unpaid care for someone with Parkinson\u2019s, including parents, adult children, siblings, or close friends. Data was analysed using reflexive thematic analysis within a critical realist paradigm.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Five focus groups were conducted with people with Parkinson\u2019s (<jats:italic>n<\/jats:italic>\u2009=\u200912) and caregivers (<jats:italic>n<\/jats:italic>\u2009=\u200912). All focus groups comprised both people with Parkinson\u2019s and caregivers. Thematic analysis identified three overarching themes: (1) The financial toll of medication and its ripple effects; (2) Lack of inclusion and support; and (3) Difficulties of seeking support. People affected by Parkinson\u2019s disagreed with current policy and suggestions of per-prescription charge re-evaluation were expressed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Prescription charges have multifaceted negative impacts on people affected by Parkinson\u2019s. Current prescription charge policies, including their exemption criteria, should be reviewed, alongside initiatives to raise awareness of existing financial support systems, such as pre-payment certificates.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Registration<\/jats:title>\n            <jats:p>Study protocol and analysis strategy are pre-registered on Open Science Framework (<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/osf.io\/y8ve5\/\" ext-link-type=\"uri\">https:\/\/osf.io\/y8ve5\/<\/jats:ext-link>).<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12889-025-24121-0","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T07:15:49Z","timestamp":1755846949000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Understanding the experience of prescription charges in people living with parkinson\u2019s disease: a focus group study"],"prefix":"10.1186","volume":"25","author":[{"given":"Megan Rose","family":"Readman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayomide","family":"Oluseye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa Jane","family":"Brighton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan","family":"Polden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Fairman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Parkinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Parkinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clarissa","family":"Giebel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,22]]},"reference":[{"issue":"4","key":"24121_CR1","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","volume":"79","author":"J Jankovic","year":"2008","unstructured":"Jankovic J. Parkinson\u2019s disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry. 2008;79(4):368\u201376.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"s1","key":"24121_CR2","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.3233\/JPD-181474","volume":"8","author":"E Dorsey","year":"2018","unstructured":"Dorsey E, Sherer T, Okun MS, Bloem BR. The emerging evidence of the Parkinson pandemic. J Parkinson\u2019s Disease. 2018;8(s1):S3\u20138.","journal-title":"J Parkinson\u2019s Disease"},{"key":"24121_CR3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.arr.2014.01.004","volume":"14","author":"A Reeve","year":"2014","unstructured":"Reeve A, Simcox E, Turnbull D. Ageing and parkinson\u2019s disease: why is advancing age the biggest risk factor? Ageing Res Rev. 2014;14:19\u201330.","journal-title":"Ageing Res Rev"},{"issue":"7","key":"24121_CR4","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1136\/jnnp.2008.162222","volume":"80","author":"MM Wickremaratchi","year":"2009","unstructured":"Wickremaratchi MM, Perera D, O\u2019Loghlen C, Sastry D, Morgan E, Jones A, Edwards P, Robertson NP, Butler C, Morris HR, Ben-Shlomo Y. Prevalence and age of onset of parkinson\u2019s disease in cardiff: a community based cross sectional study and meta-analysis. J Neurol Neurosurg Psychiatry. 2009;80(7):805\u20137.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"24121_CR5","unstructured":"Parkinson\u2019s UK. The incidence and prevalence of Parkinson\u2019s in the UK [Internet]. 2017 [cited 203 Aug 10]. Available from: https:\/\/www.parkinsons.org.uk\/sites\/default\/files\/2018-01\/Prevalence%20%20Incidence%20Report%20Latest_Public_2.pdf"},{"issue":"7310","key":"24121_CR6","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1038\/466S6a","volume":"466","author":"A Abbott","year":"2010","unstructured":"Abbott A. Levodopa: the story so far. Nature. 2010;466(7310):S6-7.","journal-title":"Nature"},{"issue":"3","key":"24121_CR7","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/mdc3.12422","volume":"4","author":"N Dahodwala","year":"2017","unstructured":"Dahodwala N, Willis AW, Li P, Doshi JA. Prevalence and correlates of anti-Parkinson drug use in a nationally representative sample. Mov Disorders Clin Pract. 2017;4(3):335\u201341.","journal-title":"Mov Disorders Clin Pract"},{"issue":"11","key":"24121_CR8","doi-asserted-by":"publisher","first-page":"e0225723","DOI":"10.1371\/journal.pone.0225723","volume":"14","author":"L Kalilani","year":"2019","unstructured":"Kalilani L, Friesen D, Boudiaf N, Asgharnejad M. The characteristics and treatment patterns of patients with parkinson\u2019s disease in the united States and united kingdom: A retrospective cohort study. PLoS ONE. 2019;14(11):e0225723.","journal-title":"PLoS ONE"},{"issue":"1","key":"24121_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12883-017-0904-4","volume":"17","author":"G McLean","year":"2017","unstructured":"McLean G, Hindle JV, Guthrie B, Mercer SW. Co-morbidity and polypharmacy in parkinson\u2019s disease: insights from a large Scottish primary care database. BMC Neurol. 2017;17(1):1\u20138.","journal-title":"BMC Neurol"},{"key":"24121_CR10","unstructured":"Department of Health and Social care. (2023, March 9) NHS prescription charges from 1 April 2023. Gov.uk. https:\/\/www.gov.uk\/government\/speeches\/nhs-prescription-charges-from-1-april-2023"},{"key":"24121_CR11","unstructured":"NHS charges [Internet]. House of Commons Library; 2024 [cited 2024 Feb 15]. Available from: https:\/\/researchbriefings.files.parliament.uk\/documents\/CBP-7227\/CBP-7227.pdf"},{"key":"24121_CR12","unstructured":"NHS Prescription Prepayment Certificate (PPC). [Internet]. NHS; [cited 2024 Jan 26]. Available from: https:\/\/www.nhsbsa.nhs.uk\/help-nhs-prescription-costs\/nhs-prescription-prepayment-certificate-ppc"},{"issue":"9","key":"24121_CR13","doi-asserted-by":"publisher","first-page":"e085345","DOI":"10.1136\/bmjopen-2024-085345","volume":"14","author":"MR Readman","year":"2024","unstructured":"Readman MR, Polden M, Brighton L, Oluseye A, Fairman I, Parkinson I, Parkinson C, Giebel C. Prescription charge policy acceptance among UK adults with and without long-term health conditions: a mixed-method survey. BMJ Open. 2024;14(9):e085345.","journal-title":"BMJ Open"},{"key":"24121_CR14","unstructured":"Prescription Charges Coalition. (2023, May). Continuing to pay the price The impact of prescription charges on people living with long term conditions. prescriptionchargescoalition.co.uk. https:\/\/www.parkinsons.org.uk\/sites\/default\/files\/2023-03\/Prescription%20charge%20report%20%28March%202023%29%20-%20final%20version.pdf"},{"issue":"6","key":"24121_CR15","first-page":"1390","volume":"10","author":"P Konstantinou","year":"2020","unstructured":"Konstantinou P, Kassianos AP, Georgiou G, Panayides A, Papageorgiou A, Almas I, Wozniak G, Karekla M. Barriers, facilitators, and interventions for medication adherence across chronic conditions with the highest non-adherence rates: a scoping review with recommendations for intervention development. Translational Behav Med. 2020;10(6):1390\u20138.","journal-title":"Translational Behav Med"},{"key":"24121_CR16","doi-asserted-by":"crossref","unstructured":"Hugtenburg JG, Timmers L, Elders PJ, Vervloet M, van Dijk L. Definitions, variants, and causes of nonadherence with medication: a challenge for tailored interventions. Patient Prefer Adherence. 2013;10:675\u201382.","DOI":"10.2147\/PPA.S29549"},{"key":"24121_CR17","doi-asserted-by":"crossref","unstructured":"Giebel C, Heath B. A 3-UK-nation survey on dementia and the cost of living crisis: contributions of gender and ethnicity on struggling to pay for social care. Aging Ment Health. 2023 Mar;30:1\u20136.","DOI":"10.1080\/13607863.2023.2197845"},{"key":"24121_CR18","doi-asserted-by":"crossref","unstructured":"Desai R, Thakkar S, Fong HK, Varma Y, Khan MZ, Itare VB, Raina JS, Savani S, Damarlapally N, Doshi RP, Gangani K. Rising trends in medication non-compliance and associated worsening cardiovascular and cerebrovascular outcomes among hospitalized adults across the United States. Cureus. 2019;11(8).","DOI":"10.7759\/cureus.5389"},{"issue":"12","key":"24121_CR19","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1592\/phco.21.20.1455.34473","volume":"21","author":"MD Schoen","year":"2001","unstructured":"Schoen MD, DiDomenico RJ, Connor SE, Dischler JE, Bauman JL. Impact of the cost of prescription drugs on clinical outcomes in indigent patients with heart disease. Pharmacotherapy: J Hum Pharmacol Drug Therapy. 2001;21(12):1455\u201363.","journal-title":"Pharmacotherapy: J Hum Pharmacol Drug Therapy"},{"key":"24121_CR20","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1007\/s00127-015-1027-0","volume":"50","author":"KM Kiely","year":"2015","unstructured":"Kiely KM, Leach LS, Olesen SC, Butterworth P. How financial hardship is associated with the onset of mental health problems over time. Soc Psychiatry Psychiatr Epidemiol. 2015;50:909\u201318.","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"24121_CR21","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.annepidem.2020.08.017","volume":"53","author":"Y Huang","year":"2021","unstructured":"Huang Y, Heflin CM, Validova A. Material hardship, perceived stress, and health in early adulthood. Ann Epidemiol. 2021;53:69\u201375.","journal-title":"Ann Epidemiol"},{"key":"24121_CR22","doi-asserted-by":"crossref","unstructured":"Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. International Journal for Quality in Health Care. 2007. Volume 19, Number 6: pp. 349\u2013357.","DOI":"10.1093\/intqhc\/mzm042"},{"key":"24121_CR23","first-page":"22","volume":"17","author":"T Greenbaum","year":"2003","unstructured":"Greenbaum T. The gold standard? Why the focus group deserves to be the most respected of all qualitative research tools. Quirk\u2019s Mark Res Rev. 2003;17:22\u20137.","journal-title":"Quirk\u2019s Mark Res Rev"},{"issue":"6","key":"24121_CR24","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1080\/13645579.2017.1281601","volume":"20","author":"G Guest","year":"2017","unstructured":"Guest G, Namey E, Taylor J, Eley N, McKenna K. Comparing focus groups and individual interviews: findings from a randomized study. Int J Soc Res Methodol. 2017;20(6):693\u2013708.","journal-title":"Int J Soc Res Methodol"},{"issue":"2","key":"24121_CR25","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1080\/2159676X.2019.1704846","volume":"13","author":"V Braun","year":"2021","unstructured":"Braun V, Clarke V. To saturate or not to saturate? Questioning data saturation as a useful concept for thematic analysis and sample-size rationales. Qualitative Res Sport Exerc Health. 2021;13(2):201\u201316.","journal-title":"Qualitative Res Sport Exerc Health"},{"issue":"2","key":"24121_CR26","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun V, Clarke V. Using thematic analysis in psychology. Qualitative Res Psychol. 2006;3(2):77\u2013101. https:\/\/doi.org\/10.1191\/1478088706qp063oa.","journal-title":"Qualitative Res Psychol"},{"issue":"163\u2013194","key":"24121_CR27","first-page":"105","volume":"2","author":"EG Guba","year":"1994","unstructured":"Guba EG, Lincoln YS. Competing paradigms in qualitative research. Handb Qualitative Res. 1994;2(163\u2013194):105.","journal-title":"Handb Qualitative Res"},{"issue":"8","key":"24121_CR28","doi-asserted-by":"publisher","first-page":"3259","DOI":"10.3758\/s13414-021-02340-y","volume":"83","author":"MR Readman","year":"2021","unstructured":"Readman MR, McLatchie NM, Poliakoff E, Crawford TJ, Linkenauger SA, Attention. Percept Psychophysics. 2021;83(8):3259\u201374.","journal-title":"Percept Psychophysics"},{"issue":"4","key":"24121_CR29","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.3758\/s13423-022-02099-9","volume":"29","author":"MR Readman","year":"2022","unstructured":"Readman MR, Longo MR, McLatchie NM, Crawford TJ, Linkenauger SA. The distorted body: the perception of the relative proportions of the body is preserved in parkinson\u2019s disease. Psychon Bull Rev. 2022;29(4):1317\u201326.","journal-title":"Psychon Bull Rev"},{"key":"24121_CR30","unstructured":"Ministry of Housing, Communities and Local Government. (2019) The English indices of deprivation 2019 - gov.uk. Available at: https:\/\/assets.publishing.service.gov.uk\/media\/5d8e26f6ed915d5570c6cc55\/IoD2019_ Statistical_Release.pdf (Accessed: 15 December 2023)."},{"key":"24121_CR31","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s40263-014-0220-0","volume":"29","author":"N Malek","year":"2015","unstructured":"Malek N, Grosset DG. Medication adherence in patients with parkinson\u2019s disease. CNS Drugs. 2015;29:47\u201353.","journal-title":"CNS Drugs"},{"issue":"23","key":"24121_CR32","doi-asserted-by":"publisher","first-page":"e10962","DOI":"10.1097\/MD.0000000000010962","volume":"97","author":"I Straka","year":"2018","unstructured":"Straka I, Min\u00e1r M, Ga\u017eov\u00e1 A, Valkovic P, Kyselovic J. Clinical aspects of adherence to pharmacotherapy in Parkinson disease: a PRISMA-compliant systematic review. Medicine. 2018;97(23):e10962.","journal-title":"Medicine"},{"key":"24121_CR33","unstructured":"Joshi MP, Clark A, Ludman M. Systems-based approaches to improving medication adherence. Submitted to the US Agency for International Development by the Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program. 2016 Nov."},{"key":"24121_CR34","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s40258-013-0033-1","volume":"11","author":"FF Richy","year":"2013","unstructured":"Richy FF, Pietri G, Moran KA, Senior E, Makaroff LE. Compliance with pharmacotherapy and direct healthcare costs in patients with parkinson\u2019s disease: a retrospective claims database analysis. Appl Health Econ Health Policy. 2013;11:395\u2013406.","journal-title":"Appl Health Econ Health Policy"},{"key":"24121_CR35","unstructured":"Aligning the upper age for NHS prescription charge exemptions. with the state pension age [Internet]. 203AD [cited 2024 Jan 15]. Available from: https:\/\/www.gov.uk\/government\/consultations\/aligning-the-upper-age-for-nhs-prescription-charge-exemptions-with-the-state-pension-age\/aligning-the-upper-age-for-nhs-prescription-charge-exemptions-with-the-state-pension-age"},{"key":"24121_CR36","unstructured":"World Health Organization. 2023 [cited 2024 Jan 31]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/parkinson-disease#:~:text=Global%20estimates%20in%202019%20showed,of%20over%20100%25%20since%202000"},{"key":"24121_CR37","unstructured":"Hex N, Mahon J, Webb A. Economic evaluation of the benefits of extending free prescriptions to people with long-term conditions. Prescription Charges Coalition. 2018."},{"issue":"9","key":"24121_CR38","doi-asserted-by":"publisher","first-page":"e0291357","DOI":"10.1371\/journal.pone.0291357","volume":"18","author":"S Crooks","year":"2023","unstructured":"Crooks S, Carter G, Wilson CB, Wynne L, Stark P, Doumas M, Rodger M, O\u2019Shea E, Mitchell G. Exploring public perceptions and awareness of parkinson\u2019s disease: A scoping review. PLoS ONE. 2023;18(9):e0291357.","journal-title":"PLoS ONE"},{"issue":"2","key":"24121_CR39","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.socscimed.2011.09.040","volume":"74","author":"RN Rooks","year":"2012","unstructured":"Rooks RN, Wiltshire JC, Elder K, BeLue R, Gary LC. Health information seeking and use outside of the medical encounter: is it associated with race and ethnicity? Soc Sci Med. 2012;74(2):176\u201384.","journal-title":"Soc Sci Med"},{"issue":"12","key":"24121_CR40","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1136\/jech.2009.089409","volume":"63","author":"J Nazroo","year":"2009","unstructured":"Nazroo J, Falaschetti E, Pierce M, Primatesta P (2009) Ethnic inequalities in access to and outcomes of healthcare: analysis of the health survey for England. J Epidemiol Community Health 63(12):1022\u20137","journal-title":"J Epidemiol Community Health"},{"issue":"5","key":"24121_CR41","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1212\/WNL.0000000000001807","volume":"85","author":"S Koga","year":"2015","unstructured":"Koga S, Aoki N, Uitti RJ, Van Gerpen JA, Cheshire WP, Josephs KA, Wszolek ZK, Langston JW, Dickson DW. When DLB, PD, and PSP masquerade as MSA: an autopsy study of 134 patients. Neurology. 2015;85(5):404\u201312.","journal-title":"Neurology"},{"key":"24121_CR42","unstructured":"Rising cost of living in the UK - house of commons library. (2024) https:\/\/commonslibrary.parliament.uk\/. Available at: https:\/\/commonslibrary.parliament.uk\/research-briefings\/cbp-9428\/ (Accessed: 21 October 2024)."}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-24121-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-025-24121-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-24121-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T19:25:51Z","timestamp":1757445951000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-025-24121-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,22]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["24121"],"URL":"https:\/\/doi.org\/10.1186\/s12889-025-24121-0","relation":{},"ISSN":["1471-2458"],"issn-type":[{"type":"electronic","value":"1471-2458"}],"subject":[],"published":{"date-parts":[[2025,8,22]]},"assertion":[{"value":"26 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study received favourable ethical approval from both the University of Liverpool [Ref: 12774], and informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All participants provided informed consent for their data to be published and no participants retracted their data following the focus groups.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2879"}}